Elaboração e avaliação de um instrumento de qualidade de vida para avaliar mucosite oral em pacientes oncológicos / Development and evaluation of a quality of life instrument to evaluate oral mucositis in cancer patients

Introdução: Mucosite oral é um efeito colateral dos tratamentos oncológicos, caracterizado por lesões orais que vão de eritema a úlceras que podem causar dor intensa e restrição de dieta. É conhecida como condição limitante e de grande impacto na qualidade de vida (QV). Objetivo: Elaborar um novo instrumento para avaliar a QV relacionada à mucosite oral. Material e método: Pesquisa através de métodos mistos, iniciando com entrevistas qualitativas analisadas pelo método de Bardin e método Reinert, com o programa IRAMUTEQ, seguido do método Delphi com quatro rodas de entrevistas e discussões com especialistas. A primeira versão do instrumento passou por um pré-teste com 10 pacientes, com análise quantitativa e qualitativa, seguido de outra rodada de especialistas. Resultados: O material das entrevistas qualitativas apontou os termos dor e alimentação como centrais na experiência de mucosite oral, além de fornecerem várias palavras-chave para definição dos constructos. Baseado nesse material e na literatura, 4 especialistas formularam 34 perguntas enviadas para outros 10 especialistas de diferentes regiões e instituições brasileiras que analisaram a clareza, ortografia e necessidade de cada pergunta para o questionário. As alterações pertinentes foram realizadas, revisadas e novamente discutidas. A primeira versão foi apresentada a 10 pacientes que não participaram das entrevistas qualitativas e responderam o grau de entendimento e necessidade de cada pergunta. A análise final do pré-teste reformulou alguns tempos verbais e palavras de difícil compreensão, dando forma a versão final do instrumento. Discussão: Embora existam bons instrumentos para mensurar QV e mucosite oral, apresentamos novas questões sobre impactos financeiros, interrupção de tratamento, alteração de saliva, perda de peso relacionada diretamente com a mucosite oral e aspectos psicossociais. Conclusão: Foi elaborado um novo instrumento para mensurar os impactos mucosite oral em pacientes oncológicos.

Elaboração e avaliação de um instrumento de qualidade de vida para avaliar mucosite oral em pacientes oncológicos / Development and evaluation of a quality of life instrument to evaluate oral mucositis in cancer patients

Introdução: Mucosite oral é um efeito colateral dos tratamentos oncológicos, caracterizado por lesões orais que vão de eritema a úlceras que podem causar dor intensa e restrição de dieta. É conhecida como condição limitante e de grande impacto na qualidade de vida (QV). Objetivo: Elaborar um novo instrumento para avaliar a QV relacionada à mucosite oral. Material e método: Pesquisa através de métodos mistos, iniciando com entrevistas qualitativas analisadas pelo método de Bardin e método Reinert, com o programa IRAMUTEQ, seguido do método Delphi com quatro rodas de entrevistas e discussões com especialistas. A primeira versão do instrumento passou por um pré-teste com 10 pacientes, com análise quantitativa e qualitativa, seguido de outra rodada de especialistas. Resultados: O material das entrevistas qualitativas apontou os termos dor e alimentação como centrais na experiência de mucosite oral, além de fornecerem várias palavras-chave para definição dos constructos. Baseado nesse material e na literatura, 4 especialistas formularam 34 perguntas enviadas para outros 10 especialistas de diferentes regiões e instituições brasileiras que analisaram a clareza, ortografia e necessidade de cada pergunta para o questionário. As alterações pertinentes foram realizadas, revisadas e novamente discutidas. A primeira versão foi apresentada a 10 pacientes que não participaram das entrevistas qualitativas e responderam o grau de entendimento e necessidade de cada pergunta. A análise final do pré-teste reformulou alguns tempos verbais e palavras de difícil compreensão, dando forma a versão final do instrumento. Discussão: Embora existam bons instrumentos para mensurar QV e mucosite oral, apresentamos novas questões sobre impactos financeiros, interrupção de tratamento, alteração de saliva, perda de peso relacionada diretamente com a mucosite oral e aspectos psicossociais. Conclusão: Foi elaborado um novo instrumento para mensurar os impactos mucosite oral em pacientes oncológicos.

Association between oral hygiene and head and neck cancer in Brazil.

INTRODUCTION: Poor oral hygiene, regular use of mouthwash and absence of visits to the dentist could correspond to potential risk factors for the development of head and neck cancer. OBJECTIVE: The objective of this study was to determine whether oral hygiene is associated with the occurrence of oral cavity and head and neck cancer in a Brazilian sample. METHOD: The variables of oral hygiene condition, such as toothbrushing frequency, dental loss, need and use of prosthesis, and regular visit to the dentist in a case-control study were analyzed in patients from five hospitals in the state of São Paulo, Brazil, paired by gender and age, from the multicenter project Genoma do Câncer de Cabeça e Pescoço (GENCAPO). RESULTS: The most frequent malignancies in the 899 patients included were those of the tongue border (11.41%) and tongue base (10.92%). The multivariable statistical analysis found odds ratio values: Brushing once 0.33 (95%CI 0.25 - 0.44); Brushing twice 0.42 (95%CI 0.35 - 0.52); Flossing always 0.19 (95%CI 0.13 - 0.27); Flossing sometimes 0.19 (95%CI 0.15 - 0.24); Bleeding 2.40 (95%CI 1.40 - 4.09); Prosthesis 1.99 (95%CI 1.54 - 2.56); Visiting the dentist 0.29 (95%CI 0.22 - 0.37); Good hygiene 0.21 (95%CI 0.17 - 0.27); Regular hygiene 0.20 (95%CI 0.15 - 0.25); number of missing teeth (6 or more) 3.30 (95%CI 2.67 - 4.08). CONCLUSION: These data showed that, in the population studied, indicators of good hygiene such as brushing teeth and flossing were protective factors for mouth and head and neck cancer, while bleeding and many missing teeth were risk factors.

Dental caries in South American Indigenous peoples: A systematic review.

OBJECTIVES: To determine the severity of dental caries in South American Indigenous peoples. METHODS: A systematic review was conducted regarding the severity of dental caries in South American Indigenous peoples using the following electronic databases: MEDLINE/PubMed, SCOPUS, SciELO, LILACS and grey literature up to March 2018. Literature search was conducted up to March 2018. No restrictions on language or year of publication were applied. Descriptive analysis and meta-analysis of studies were performed to determine mean dmft/DMFT index (decayed, missing and filled teeth) and temporal trends for selected age brackets. RESULTS: The search strategy retrieved 698 studies, of which 70 full-text articles were assessed for eligibility and 28 were included in the qualitative analysis. Finally, 18 papers were included in the meta-analysis. Publication year ranged from 1964 to 2018. Mean dmft for 5-year-old children was 5.73 (95% CI 4.67-6.79), and mean DMFT for 12-year-olds was 3.14 (95% CI 1.88-4.40). Estimated DMFT for 15-19 years, 35-44 years and 65-74 years was 5.53 (95% CI 2.97-8.09), 19.41 (95% CI 11.88-26.93) and 28.19 (24.83-31.55), respectively. DMFT was higher than that reported in general population surveys in Brazil, Chile, Uruguay and Venezuela for all age brackets with available data. Heterogeneity was observed in all age brackets, ranging from 79.7 to 99.7%. CONCLUSION: Dental caries remains a significant public health problem for South American Indigenous peoples. Prevention and treatment strategies that consider cultural specificities are needed.

Functional dentition and prosthodontic status in an Indigenous population from the South of Brazil

Aim: to analyze the prevalence of different definitions of functional dentition, prosthodontic status and associated factors, in an indigenous population from Brazil. Methods: a cross-sectional oral health survey was conducted with Indigenous adults aged 35-44 years. A single examiner collected clinical data through oral examinations and sociodemographic data using a structured questionnaire. Dentitions were classified according to four classification systems of functional dentition: FDWHO (> 20 teeth), FDGROUP2 (> 10 teeth in each arch), FDGROUP3 (all anterior teeth), and FDGROUP4 (> 10 teeth in each arch, all anterior teeth, and sufficient posterior region). Use and need of prosthodontics was also evaluated. Uni and multivariate analysis were conducted at the level of significance of 5%. Results: Indigenous adults presented considerably low frequencies of prosthodontic use and functional dentition, independently of the definition analyzed. Substantial differences of prevalence rates were observed among the four definitions of functional dentition, ranging from 48.62% to 11.93%. Age and municipality were associated with use of dental prosthesis and prosthodontic need, respectively. Significant discrepancies in functional dentition rates were observed regarding sex and time of the last dental appointment. Conclusions: Indigenous adults are severely affected by tooth loss and, consequently, by low frequencies of functional dentition. The scenario is worsened by the elevated need of the population for prosthodontics. The phenomenon was associated with age, sex, access to specialized dental care and time of the last dental visit

Measurement of oral health quality of life among patients who underwent haematopoietic stem-cell transplantation.

Oral mucositis is a painful condition that occurs in patients who have undergone haematopoietic stem-cell transplantation (HSCT) and has a huge impact on their quality of life. The objective of this study was to examine the extent to which interleukin-6 (IL-6) and tumour necrosis factor alpha (TNF-α) are associated with oral health quality of life among patients who underwent HSCT. A. C. Camargo Cancer Center patients were evaluated over 20 months at 4 different time-points: a) at patient admission (M1); b) on the day of infusion of HSC (M2); c) 12 and 20 days after the first day of the conditioning regimen for autologous and allogeneic transplantation, respectively (M3); and d) 30 days after the first day of the conditioning regimen (M4). Mucositis clinical evaluations were performed using World Health Organization (WHO) criteria. Oral health quality of life was measured using the Oral Health Impact Profile short form (OHIP-14), Oral Mucositis Quality of Life (OMQoL) and Patient-Reported Oral Mucositis Symptom (PROMS) scales. Correlations between clinical data and quality of life scores were examined. STATA 11.0 was used to perform the statistical analyses (5% level of significance). Eighty-two patients participated in the study; 62.2% were male, 28.05% had multiple myeloma, and the mean age was 48.49 years (SD 13.76). Higher scores (worse quality of life) were observed as mucositis scores increased, but the results were not significant. The OMQoL had a high correlation with OHIP-14 (0.8377), but the correlation between the PROMS scale and the OHIP-14 was lower (0.6643). Higher concentrations of IL-6 and TNF-α were associated with worse quality of life, according to all indices (p < 0.05). Oral mucositis was associated with quality of life scores (p < 0.01).

Measurement of oral health quality of life among patients who underwent haematopoietic stem-cell transplantation

Abstract Oral mucositis is a painful condition that occurs in patients who have undergone haematopoietic stem-cell transplantation (HSCT) and has a huge impact on their quality of life. The objective of this study was to examine the extent to which interleukin-6 (IL-6) and tumour necrosis factor alpha (TNF-α) are associated with oral health quality of life among patients who underwent HSCT. A. C. Camargo Cancer Center patients were evaluated over 20 months at 4 different time-points: a) at patient admission (M1); b) on the day of infusion of HSC (M2); c) 12 and 20 days after the first day of the conditioning regimen for autologous and allogeneic transplantation, respectively (M3); and d) 30 days after the first day of the conditioning regimen (M4). Mucositis clinical evaluations were performed using World Health Organization (WHO) criteria. Oral health quality of life was measured using the Oral Health Impact Profile short form (OHIP-14), Oral Mucositis Quality of Life (OMQoL) and Patient-Reported Oral Mucositis Symptom (PROMS) scales. Correlations between clinical data and quality of life scores were examined. STATA 11.0 was used to perform the statistical analyses (5% level of significance). Eighty-two patients participated in the study; 62.2% were male, 28.05% had multiple myeloma, and the mean age was 48.49 years (SD 13.76). Higher scores (worse quality of life) were observed as mucositis scores increased, but the results were not significant. The OMQoL had a high correlation with OHIP-14 (0.8377), but the correlation between the PROMS scale and the OHIP-14 was lower (0.6643). Higher concentrations of IL-6 and TNF-α were associated with worse quality of life, according to all indices (p < 0.05). Oral mucositis was associated with quality of life scores (p < 0.01).